GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons

  January 10, 2024 -- InvestorsHub NewsWire -- via NetworkNewsWire Editorial Coverage: On Sept. 20, 2019, history was made when...

Form 3 - Initial statement of beneficial ownership of securities

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

September 20, 2023 -- InvestorsHub NewsWire -- via NetworkNewsWire Editorial Coverage: More than 30 million people in the United States...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:March 31, 2023...

Securities Registration (ads, Delayed) (f-6)

  As filed with the U.S. Securities and Exchange Commission on March 21, 2023.  Registration No.  333-   ...

Roche to provide HIV diagnostic solutions to Global Fund

Roche to provide HIV diagnostic solutions to Global Fund PR Newswire PLEASANTON, California, June 18, 2015 - Framework agreement with Global Fund...

Clinical value of Roche's CINtec® PLUS Cytology test confirmed for women with abnormal cervical cytology screening results

Clinical value of Roche's CINtec® PLUS Cytology test confirmed for women with abnormal cervical cytology screening results PR Newswire TUCSON...

Ventana receives FDA approval for the first fully automated IHC companion diagnostic to identify lung cancer patients eligibl...

Ventana receives FDA approval for the first fully automated IHC companion diagnostic to identify lung cancer patients eligible for XALKORI®...

Ariosa grants licenses to laboratories to perform non-invasive prenatal testing (NIPT) based on Harmony™ Prenatal Test tech...

Ariosa grants licenses to laboratories to perform non-invasive prenatal testing (NIPT) based on Harmony™ Prenatal Test technology PR Newswire SAN...

Roche To Develop Companion Diagnostic Test For Acute Coronary Syndrome

Roche To Develop Companion Diagnostic Test For Acute Coronary Syndrome PR Newswire PLEASANTON, California, June 9, 2015 -- Agreement with DalCor...

Roche receives FDA clearance for the cobas® HSV 1 and 2 Test for the detection of herpes simplex virus

Roche receives FDA clearance for the cobas® HSV 1 and 2 Test for the detection of herpes simplex virus New test expands menu for sexually...